Iris Joosse was trained as a pharmacist at Utrecht University. Iris is currently a postdoctoral researcher and teacher at the division of Pharmacoepidemiology & Clinical Pharmacology at the Utrecht Institute of Pharmaceutical Sciences (UIPS). 

She completed her PhD in 2024, focusing on improving access to medicines in low- and middle-income countries. Her research advanced methods to monitor pediatric access to essential medicines, evaluated the impact of pharmaceutical pricing policies on access and usage of medicines, and introduced innovative approaches to studying access to medicines from a health systems perspective. As part of her doctoral studies, Iris conducted research in Durban, South Africa, enhancing her insights into the challenges of healthcare access in diverse contexts.

In her postdoctoral work, Iris is involved in two multi-country consortium projects. In the Control-EU project, she contributes to research on the implementation of controlled access and distribution programs for medicinal products across the European Union. This work aims to provide evidence of the feasibility and need for these additional risk minimization measures within the EU regulatory framework.

In her second project, Iris supports the implementation of the EU Health Technology Assessment (HTA) Regulation in Luxembourg, Malta, and Slovenia, helping to build readiness and capacity in these countries as they prepare to meet new HTA compliance standards. 

As a teacher, she is involved in various courses within the bachelor and master programs of Pharmacy, including but not limited to elective courses on access to medicines in diverse healthcare settings.